Better Therapeutics, Inc.

BTTXOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$5452

P/E Ratio—

52W High$0.001

52W Low$0.0001

Avg Volume4K

Open$0.00

Beta1.69

Earnings Financials Revenue

Better Therapeutics, Inc. (BTTX) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BTTX · earnings · updated Jun 8, 2026

Latest Earnings

Q4 FY2023Report Date: Nov 9, 2023

EPS Actual

-$0.15

Est. -$0.19 · +21.1%

Revenue

—

Fiscal Period

Q4 FY2023

FY ends December

Report Date

Nov 9, 2023

After Market Close

▲ Beat EPS✓ 2-Quarter EPS Beat Streak

BTTX reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 13, 2026	-$0.21	—	—	—	$0.01B	—
◌ Q2 FY2026	May 29, 2026	-$0.22	—	—	—	$0.01B	—
◌ Q2 FY2026	Apr 2, 2026	-$0.27	—	—	—	$0.00B	—
◌ Q2 FY2025	Jun 4, 2025	—	—	—	—	—	—
◌ Q2 FY2025	May 29, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 28, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Dec 27, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Sep 25, 2024	-$0.12	—	—	—	—	—

Q3 FY2026

Aug 13, 2026

EPS Actual

—

EPS Est.

-$0.21

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 29, 2026

EPS Actual

—

EPS Est.

-$0.22

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 2, 2026

EPS Actual

—

EPS Est.

-$0.27

EPS Surpr.

—

Revenue

—

Q2 FY2025

Jun 4, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 27, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 25, 2024

EPS Actual

—

EPS Est.

-$0.12

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2026	$-0.15	$-0.15	$-0.15	1
Q3 FY2026	$-0.18	$-0.18	$-0.18	1
Q2 FY2026	$-0.21	$-0.21	$-0.21	1
Q1 FY2026	$-0.22	$-0.22	$-0.22	1
Q4 FY2025	$-0.27	$-0.27	$-0.27	1
Q3 FY2025	$-0.27	$-0.27	$-0.27	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2026	$0.0B	$0.0B	$0.0B	1
Q3 FY2026	$0.0B	$0.0B	$0.0B	1
Q2 FY2026	$0.0B	$0.0B	$0.0B	1
Q1 FY2026	$0.0B	$0.0B	$0.0B	1
Q4 FY2025	$0.0B	$0.0B	$0.0B	1
Q3 FY2025	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q4 FY2023	Nov 9, 2023	+21.1%	$0.16	$0.15	-3.47%
▲ Q3 FY2023	Aug 9, 2023	+38.5%	$0.72	$0.74	+2.78%

Q4 FY2023-3.47%

Report Date

Nov 9, 2023

EPS Beat/Miss

+21.1%

Price Before

$0.16

Price After

$0.15

Q3 FY2023+2.78%

Report Date

Aug 9, 2023

EPS Beat/Miss

+38.5%

Price Before

$0.72

Price After

$0.74

Avg Beat Reaction-0.35%

Beat Rate2 / 2 quarters

Largest Move-3.47% (Q4 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Better Therapeutics, Inc. (BTTX) most recently reported earnings on November 9, 2023 for Q4 FY2023, posting EPS of $-0.15 — beating the analyst consensus of $-0.19 by +21.1%. BTTX has beaten EPS estimates for 2 consecutive quarters. The next BTTX earnings date is expected around September 1, 2026.

Each quarter, investors track BTTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BTTX revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BTTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BTTX earnings · 5 questions

Better Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. BTTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BTTX historically reports after market close (AMC).

BTTX earnings datewhen is BTTX earningsBTTX next earnings datewhen does BTTX report earningsBTTX earnings calendar

▸ Source: FMP · Better Therapeutics, Inc. SEC filings · US GAAP · Better Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026